Alexander Hajduczok, MD πΊπ¦π
@AHajduczok
@TJHeartFellows Cards Fellow PGY-6 | Future @UCSDCardiology Adv HF Fellow | Remote Monitoring, Hemodynamics | @whoop | @JCardFail FIT editor | Go Bills
ID:1237481410765692936
https://linktr.ee/ahajduczok 10-03-2020 20:52:58
19,8K Tweets
8,8K Followers
5,3K Following
Fired up to start #ESCPrev2024 and #sportscards sessions! Great seeing some sights yesterday with β¦Matthew W Martinezβ©. β¦Prof Michael Papadakisβ© β¦Eugene Yangβ©
Love this list. Iβve been fortunate to have fantastic mentors who Iβve learned many of these lessons from Navin Kapur Ryan J Tedford MD & Michael Zile.
We're proud to make Journal of Cardiac Failure the home for this important work!
Robert Mentz, MD Anu Lala-Trindade Andrew J Sauer MD Dr. Martha Gulati β₯οΈπ«β€οΈβπ©Ήπ¨π¦ πππππππππ ππππ, ππ.π πβοΈπ»π§‘ Quentin Youmans, MD, MSc, FACC Ashish Correa Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP,CACP Vanessa Blumer, MD, FACC Emer Joyce HFSA
π₯ Out now in our April issue! πΈ
A State of the Art Review on Durable MCS devices by Seraina Dual & colleagues. Everything you need to know, including unmet needs, emerging technologies & the future of MCS.
π bit.ly/3wC1QAf
BLyS inhibitors were effective in inhibiting B-cell activation/differentiation, reducing antibody production & prolonging allograft survival. BLyS inhibitors could be used for prevention of chronic rejection in practice. cc @ahajduczok Rachna Kataria, MD
π jhltonline.org/article/S1053-β¦
Great time this weekend celebrating Ramya Bodempudi MDβs beautiful wedding in DC along with the Jefferson Cardiology Fellows - Brian Osler, MD Rachel Laulusa Debenham Khulkar Mirzozoda Sebastian Rodriguez Aditya Munshi
Great day screening hearts with SIMON'S Heart along with Brian Osler, MD Sports Cardiology and team!! β€οΈβ€οΈβ€οΈ
Only fitting during #Sarcoidosis Awareness Month our first presentation on rounds today is a cardiac #sarcoidosis patient. And that #Osler teaching included the hot-off-the-press AHA Science Guidelines Statement on Sarcoidosis Diagnosis and Treatment by none other than
Quick poll:
Do you think heart rate variability (HRV) should be a metric we track in patients to predict future CV events including MI complications post STEMI and HF exacerbations?
Alexander Hajduczok, MD πΊπ¦π Ryan J Tedford MD Robert Mentz, MD Nosheen Reza, MD Jason N. Katz Sunil V. Rao Steve Hsu
In a multi-center cohort, the HM3 risk score provided adequate risk discrimination in βtrial-likeβ pts but was less predictive in pts who did not meet trial criteria Ryan J Tedford MD Mandeep R. Mehra, MBBS, MSc, FRCP (London) Farooq Sheikh Jagpreet Grewal Alexander Hajduczok, MD πΊπ¦π
π jhltonline.org/article/S1053-β¦
#FreakyFridayCardsEdition from team #JAST a novel use of SBRT for VT in LVAD!
Jenna Campbell Anjeli Patel Samir Mehta
We shine the spotlight on Dr. Jeffrey Hsu, awarded the American Heart Association Second Century Early Faculty Independence Award for his project aimed at creating a wearable biosensor to transform exercise monitoring and guidance for patients w/ heart conditions. bit.ly/49J7EWf